• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL INC. REDIGUARD IAB: 8FR 40CC; INTRA- AORTIC BALLOOON PRODUCTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL INC. REDIGUARD IAB: 8FR 40CC; INTRA- AORTIC BALLOOON PRODUCTS Back to Search Results
Catalog Number IAB-S840C
Device Problem Fluid/Blood Leak (1250)
Patient Problems Vessel Or Plaque, Device Embedded In (1204); Congestive Heart Failure (1783); Device Embedded In Tissue or Plaque (3165)
Event Date 09/27/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that the (intra-aortic balloon) iab catheter was inserted without complications.Several hours later the balloon ruptured in the patient's aorta.An attempt to extract the balloon failed.At the time of this report the patient is undergoing an "open operation." additional information was received 09/30/2016: the iab was inserted via the patients left femoral artery while in the operating theatre.The patient was subjected to iab counter pulsation procedure after coronary bypass grafting (cabg) aiming to prevent heart failure.While in the intensive care unit (icu) and after approximately 10 hours of iabp therapy the pump alarmed and there was blood leakage into the connection tube.The iabp therapy was interrupted and the attempt to remove the iab using endovascular method was performed.With the help of x-ray imaging it was discovered that the balloon is broken.The md's had to call vascular surgeons, who performed the open surgery (opened the aorta) and removed the balloon catheter.The patient remains in critical condition.The interruption in iabp therapy did cause harm to the patient.Additional information received 10/03/16: the patient is still alive and the physicians are closely monitoring her condition.It was possible during the open op to extract the fragments of the balloon.
 
Manufacturer Narrative
(b)(4).The serial number was not reported.The bifurcate was not returned with the catheter.The reported lot number (18f15j0054) matches the upc label returned with the device.The serial number on the returned upc label is (b)(4).Returned for evaluation was a significantly damaged 40cc 8.0fr iab in a white shipping box.The device was returned in a glove.Approximately 22.0cm of the bladder membrane was returned.Blood was noted within the returned bladder membrane.The rest of the device was not returned for evaluation.A cd was returned with the device.The central lumen was found piercing the bladder membrane approximately 15.0cm from the returned distal tip.The device could not be functionally tested because of the damaged sate of the catheter upon return.The x-ray on the cd was opened; however, the cause of the complaint could not be determined from the returned pictures.A device history record (dhr) review was conducted for the lot number/serial number with no relevant findings.The device passed all manufacturing specifications prior to release.Conclusion: the reported complaint of blood in the helium pathway is confirmed based on visual inspection of the device.Blood was noted in the returned bladder membrane; however, the device could not be functionally tested due to the damaged state of the device upon return.The root cause of the complaint is undetermined.
 
Event Description
It was reported that the (intra-aortic balloon) iab catheter was inserted without complications.Several hours later the balloon ruptured in the patient's aorta.An attempt to extract the balloon failed.At the time of this report the patient is undergoing an "open operation." additional information was received 09/30/2016: the iab was inserted via the patients left femoral artery while in the operating theatre.The patient was subjected to iab counter pulsation procedure after coronary bypass grafting (cabg) aiming to prevent heart failure.While in the intensive care unit (icu) and after approximately 10 hours of iabp therapy the pump alarmed and there was blood leakage into the connection tube.The iabp therapy was interrupted and the attempt to remove the iab using endovascular method was performed.With the help of x-ray imaging it was discovered that the balloon is broken.The md's had to call vascular surgeons, who performed the open surgery (opened the aorta) and removed the balloon catheter.The patient remains in critical condition.The interruption in iabp therapy did cause harm to the patient.Additional information received 10/03/16: the patient is still alive and the physicians are closely monitoring her condition.It was possible during the open op to extract the fragments of the balloon.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REDIGUARD IAB: 8FR 40CC
Type of Device
INTRA- AORTIC BALLOOON PRODUCTS
Manufacturer (Section D)
ARROW INTERNATIONAL INC.
reading PA
Manufacturer (Section G)
ARROW INTERNATIONAL INC.
9 plymouth street
everett MA 02149
Manufacturer Contact
anne rosenberger
2400 bernville road
reading, PA 19605
6104783117
MDR Report Key6057609
MDR Text Key58401217
Report Number1219856-2016-00237
Device Sequence Number1
Product Code DSP
Combination Product (y/n)N
Reporter Country CodeUP
PMA/PMN Number
K981660
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/27/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/26/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2017
Device Catalogue NumberIAB-S840C
Device Lot Number18F15J0054
Other Device ID Number00801902002679
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/11/2016
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/22/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/29/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
-
-